|Articles|July 11, 2013

Next Pharmaceuticals Acquires Rights to Sytrinol Heart-Health Ingredient

Research shows Sytrinol significantly improves total cholesterol, LDL cholesterol, and triglyceride levels up to 30%, 27%, and 34%, respectively.

Next Pharmaceuticals (Salinas, CA) has purchased the future worldwide distribution rights to Sytrinol, a patented ingredient aimed at heart health, derived from natural citrus and palm fruit extracts. Supplier Proprietary Nutritionals Inc. (Kearny, NJ) holds the distribution rights to Sytrinol until the end of this year. Next Pharmaceuticals will own the rights, including patents, trademarks, and scientific property, purchased from the ingredient’s Canada-based research and development firm KGK Synergize.

Sytrinol combines polymethoxylated flavones and delta-, gamma-, and alpha-tocotrienols.The companies say clinical research shows Sytrinol significantly improves total cholesterol, LDL cholesterol, and triglyceride levels up to 30%, 27%, and 34%, respectively, compared to placebo, as well as increases HDL cholesterol.

From ingredient science to consumer trends, get the insights you need to stay competitive in the nutrition industry. Subscribe to Nutritional Outlook today.

Related to this article

November 2nd, 2026

Vitaquest's 2027 Consumer Trends Forecast

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.

November 2nd, 2026

What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands

The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.

October 30th, 2026

The Expanding Science of Magtein

Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.

October 30th, 2026

Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods

Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.

October 29th, 2026

SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition

Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.

October 29th, 2026

Beauty-from-Within Meets Gut Health

Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.

October 28th, 2026

The Reason Behind Pairing Sea Buckthorn Oil and Thymoquinone

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Mit Metah, executive vice president at Unibar, about the launch of ElaQuin and how it connects to Bellaneo, Unibar’s melanin-inhibiting cosmeceutical ingredient.